Antiphospholipid Antibody Syndrome Completed Phase Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0029330 (Antiphospholipid Antibody Syndrome)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00010400Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody SyndromeTreatment